Dr. Charles D. Lopez
Claim this profileOHSU Knight Cancer Institute
Area of expertise
Pancreatic Cancer
Charles D. Lopez has run 6 trials for Pancreatic Cancer. Some of their research focus areas include:
Pancreatic Adenocarcinoma
Charles D. Lopez has run 2 trials for Pancreatic Adenocarcinoma. Some of their research focus areas include:
Affiliated Hospitals
OHSU Knight Cancer Institute
Oregon Health And Science University
Clinical Trials Charles D. Lopez is currently running
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting
0 awards
Phase 2
32 criteria
Targeted Drug Therapy
for Pancreatic Cancer
This trial is testing four experimental drugs to see if they can help treat pancreatic cancer. The drugs work by blocking important processes that cancer cells need to grow and survive. The trial focuses on patients with pancreatic cancer who do not respond well to standard treatments. Gemcitabine was the first agent investigated for its potential to improve symptoms and overall well-being in pancreatic cancer patients.
Recruiting
1 award
Phase < 1
More about Charles D. Lopez
Clinical Trial Related
4 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Charles D. Lopez has experience with
- Cobimetinib
- Olaparib
- Onvansertib
- Nab-paclitaxel
- Fluorouracil
- Irinotecan Hydrochloride
Breakdown of trials Charles D. Lopez has run
Pancreatic Cancer
Pancreatic Adenocarcinoma
Pancreatic intraepithelial neoplasia
Rectal Cancer
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Charles D. Lopez specialize in?
Charles D. Lopez focuses on Pancreatic Cancer and Pancreatic Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Charles D. Lopez currently recruiting for clinical trials?
Yes, Charles D. Lopez is currently recruiting for 2 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Charles D. Lopez has studied deeply?
Yes, Charles D. Lopez has studied treatments such as Cobimetinib, Olaparib, Onvansertib.
What is the best way to schedule an appointment with Charles D. Lopez?
Apply for one of the trials that Charles D. Lopez is conducting.
What is the office address of Charles D. Lopez?
The office of Charles D. Lopez is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.